17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T23434 | GPR35 agonist 2 | TC-G 1001 | GPR , Arrestin |
GPR35 agonist 2 (TC-G 1001) is a potent GPR35 agonist.The EC50 values of GPR35 agonist 2 in the β-arrestin and Ca2+ release assays were 26 and 3.2 nM, respectively. | |||
T11455 | GPR35 agonist 1 | Others | |
GPR35 agonist 1 is a highly effective and specific GPR35/CXCR8 agonist (EC50: 5.8 nM). | |||
T72755 | GPR35 agonist 3 | ||
GPR35 agonist 3, a synthetic compound, acts as an agonist for GPR35 with an EC50 value of 1.4 μM and is utilized in researching numerous diseases including gastric cancer, type 2 diabetes, cardiovascular diseases, and di... | |||
T9162 | CID1231538 | GPR | |
CID1231538 is a potent GPR35 antagonist. | |||
T21874 | CID 2745687 | GPR | |
CID 2745687 is a GPR35 antagonist that inhibited the effects at human GPR35 of cromolyn disodium and zaprinast, two agonists that share an overlapping binding site. | |||
T21622 | Tyrphostin A25 | AG-82,Tyrphostin AG 82,RG-50875 | EGFR , GPR |
Tyrphostin A25 (Tyrphostin AG 82) is a specific EGFR tyrosine kinase inhibitor and GPR35 agonist with an IC50 value of 0.94 μM for GPR35 and an EC50 value of 5.3 μM for GPR35. | |||
T2129 | Zaprinast | PDE | |
Zaprinast is a cGMP-selective phosphodiesterase (PDE) inhibitor and a GPR35 agonist. It has a strong activating effect on rat GPR35 and a certain activating effect on human GPR35. It reduces vascular remodeling through a... | |||
T22103 | ML-193 | CID 1261822 | Cannabinoid Receptor |
ML-193 (CID 1261822) is a potent and selective GPR55 antagonist( IC50 : 221 nM). It shows more than 27-fold selectivity for GPR55 over GPR35, CB1 and CB2, and can improve the motor and the sensorimotor deficits of Parkin... | |||
T65135 | Kynurenic acid | Fibrostop 2,Quinurenic acid | GPR , GluR , NMDAR |
Kynurenic acid (Quinurenic acid) is an endogenous tryptophan active metabolite, a triple antagonist of NMDA, glutamate, α7 nicotinic acetylcholine receptor, and an agonist of GPR35/CXCR8 with neuroprotective and anticonv... | |||
T8571 | ML-184 | CID2440433 | Cannabinoid Receptor |
ML-184 (CID2440433) is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM. | |||
T23120 | Pamoic acid disodium | Pamoic acid disodium salt | Others |
Pamoic acid disodium is a GPR35 agonist. | |||
T22158 | TCS 3035 | ||
GPR35 agonist 4 (compound 10) serves as a potent GPR35 agonist, showcasing a pEC50 of 5.86, indicating its high potency towards both human and rat GPR35. Notably, the mutation of arginine at position 3.36 results in the ... | |||
T23542 | YE 120 | Others | |
YE 120 is a GPR35 agonist. | |||
T12074 | ML 145 | Others | |
ML 145 is a selective antagonist of GPR35/CXCR8 (IC50/EC50 of 20.1 nM) | |||
T73665 | Bufrolin | ||
Bufrolin, an analog of Cromoglycate (histamine release inhibitor) and a potent agonist of GPR35, enhances the interaction between β-arrestin-2 and both human GPR35a and rat GPR35. It stabilizes mast cells, exhibiting ant... | |||
TQ0075 | ML314 | Neurotensin Receptor | |
ML314 is a brain-permeable nonpeptide β-inhibin-biased neurotensin NTR1 receptor agonist (EC50: 1.9 μM), a biased neurotensin receptor ligand for methamphetamine abuse that inhibits NTR2 and GPR35. | |||
T37529 | TC NTR1 17 | ||
Non-peptide neurotensin receptor 1 (NTS1) partial agonist (EC50 <15.6 nM and Emax = 63% of neurotensin response in Ca2+ mobilization assay). Exhibits over 50-fold selectivity for NTS1 over NTS2 and GPR35. Hershberger et ... |